|4/AApr 7, 8:46 AM ET

Jene Jill M. 4/A

4/A · PDL BIOPHARMA, INC. · Filed Apr 7, 2020

Insider Transaction Report

Form 4/AAmended
Period: 2020-01-08
Jene Jill M.
VP, Business Development
Transactions
  • Award

    Common stock

    2020-01-08+194,805194,805 total
Footnotes (1)
  • [F1]The restricted stock units will vest as follows: (a) 40% of the shares subject to the award shall vest on the one year anniversary of the grant date and (b) 2.5% of the shares subject to the award shall vest monthly thereafter; provided that recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control.

Documents

1 file
  • 4
    wf-form4a_158626360070465.xml

    FORM 4/A